Q32 Bio Analyst Price Targets

Wall Street analyst price targets and consensus rating for Q32 Bio (QTTB).

Price Target Range — 8 Quarters

Analyst Consensus — 12 Analysts

9Buy

3Hold

Consensus RatingOutperform# Analysts12Avg. Consensus PT$33Upside to Avg. PT+340.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 12, 2026	Leerink Partners	Will Soghikian	Initiate	Outperform	$40
Sep 28, 2026	Jefferies	Maury Raycroft	Initiate	Buy	$29
Aug 24, 2026	Morgan Stanley	Judah Frommer	Initiate	Overweight	$34
Jul 28, 2026	HC Wainwright & Co.	Joseph Pantginis	PT Raise	Buy	$13→$36
Jul 13, 2026	Wells Fargo	Derek Archila	Upgrade	Equal-Weight→Overweight	$66
Jul 13, 2026	Oppenheimer	Jay Olson	PT Raise	Outperform	$20→$40
May 22, 2026	Mizuho	Joseph Catanzaro	Initiate	Outperform	$14
May 18, 2026	Cantor Fitzgerald	—	Initiate	Overweight	—
May 5, 2026	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$13
Feb 25, 2026	HC Wainwright & Co.	Joseph Pantginis	Initiate	Buy	$13
Mar 12, 2025	Wells Fargo	Derek Archila	PT Cut	Equal-Weight	$16→$15
Feb 11, 2025	BMO Capital	Etzer Darout	Downgrade	Outperform→Market Perform	$22→$3
Feb 11, 2025	Piper Sandler	Christopher Raymond	Downgrade	Overweight→Neutral	$20→$4
Dec 12, 2024	BMO Capital	Etzer Darout	PT Cut	Outperform	$64→$22
Dec 12, 2024	Guggenheim	Yatin Suneja	Downgrade	Buy→Neutral	—
Dec 11, 2024	Oppenheimer	Jay Olson	PT Cut	Outperform	$80→$20
Dec 11, 2024	Piper Sandler	Christopher Raymond	PT Cut	Overweight	$85→$20
Dec 11, 2024	Wells Fargo	Derek Archila	Downgrade	Overweight→Equal-Weight	$95→$16
Dec 11, 2024	Leerink Partners	Thomas Smith	Downgrade	Outperform→Market Perform	$68→$9
Dec 11, 2024	Raymond James	Steven Seedhouse	Downgrade	Strong Buy→Outperform	$90→$22

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Leerink Partners Initiates Coverage On Q32 Bio with Outperform Rating, Announces Price Target of $40

Leerink Partners analyst Will Soghikian initiates coverage on Q32 Bio (NASDAQ:QTTB) with a Outperform rating and announces Price Target of $40.

Benzinga Newsdesk

PRO
Jefferies Initiates Coverage On Q32 Bio with Buy Rating, Announces Price Target of $29

Jefferies analyst Maury Raycroft initiates coverage on Q32 Bio (NASDAQ:QTTB) with a Buy rating and announces Price Target of $29.

Benzinga Newsdesk

PRO
Morgan Stanley Initiates Coverage On Q32 Bio with Overweight Rating, Announces Price Target of $34

Morgan Stanley analyst Judah Frommer initiates coverage on Q32 Bio (NASDAQ:QTTB) with a Overweight rating and announces Price Target of $34.

Benzinga Newsdesk

Twilio To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on top names. For a complete view, see analyst ratings page. See how others view these stocks.

Avi Kapoor

PRO
HC Wainwright & Co. Maintains Buy on Q32 Bio, Raises Price Target to $36

HC Wainwright & Co. analyst Joseph Pantginis maintains Q32 Bio (NASDAQ:QTTB) with a Buy and raises the price target from $13 to $36.

Benzinga Newsdesk

PRO
Wells Fargo Upgrades Q32 Bio to Overweight, Announces $66 Price Target

Wells Fargo analyst Derek Archila upgrades Q32 Bio (NASDAQ:QTTB) from Equal-Weight to Overweight and announces $66 price target.

Benzinga Newsdesk

Q32 Bio Inc

Q32 Bio Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Leerink Partners Initiates Coverage On Q32 Bio with Outperform Rating, Announces Price Target of $40

PRO
Jefferies Initiates Coverage On Q32 Bio with Buy Rating, Announces Price Target of $29

PRO
Morgan Stanley Initiates Coverage On Q32 Bio with Overweight Rating, Announces Price Target of $34

Twilio To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Tuesday

PRO
HC Wainwright & Co. Maintains Buy on Q32 Bio, Raises Price Target to $36

PRO
Wells Fargo Upgrades Q32 Bio to Overweight, Announces $66 Price Target

People Also Watch

People Also Watch

Q32 Bio Inc

Q32 Bio Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROLeerink Partners Initiates Coverage On Q32 Bio with Outperform Rating, Announces Price Target of $40

PROJefferies Initiates Coverage On Q32 Bio with Buy Rating, Announces Price Target of $29

PROMorgan Stanley Initiates Coverage On Q32 Bio with Overweight Rating, Announces Price Target of $34

Twilio To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Tuesday

PROHC Wainwright & Co. Maintains Buy on Q32 Bio, Raises Price Target to $36

PROWells Fargo Upgrades Q32 Bio to Overweight, Announces $66 Price Target

People Also Watch

People Also Watch

PRO
Leerink Partners Initiates Coverage On Q32 Bio with Outperform Rating, Announces Price Target of $40

PRO
Jefferies Initiates Coverage On Q32 Bio with Buy Rating, Announces Price Target of $29

PRO
Morgan Stanley Initiates Coverage On Q32 Bio with Overweight Rating, Announces Price Target of $34

PRO
HC Wainwright & Co. Maintains Buy on Q32 Bio, Raises Price Target to $36

PRO
Wells Fargo Upgrades Q32 Bio to Overweight, Announces $66 Price Target